Seeing Is Believing
PCRX is currently covered by 11 analysts with an average price target of $28.86. This is a potential upside of $9.03 (45.54%) from yesterday's end of day stock price of $19.83.
Pacira Pharmaceuticals's activity chart (see below) currently has 239 price targets and 241 ratings on display. The stock rating distribution of PCRX is 9.26% HOLD and 90.74% BUY.
Analysts average stock forecasts to be materialized ratio is 68.78% with an average time for these price targets to be met of 324.67 days.
Highest price target for PCRX is $57, Lowest price target is $10, average price target is $28.86.
Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 04-Dec-2024. First documented stock forecast 18-Jan-2013.
Currently out of the existing stock ratings of PCRX, 5 are a HOLD (9.26%), 49 are a BUY (90.74%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$39
$19.14 (96.37%)
$39
14 days ago
(04-Dec-2024)
13/27 (48.15%)
$21.25 (119.72%)
233
Hold
$17
$-2.86 (-14.40%)
$25
1 months 6 days ago
(12-Nov-2024)
3/11 (27.27%)
$0.06 (0.35%)
291
Buy
$22
$2.14 (10.78%)
$22
1 months 10 days ago
(08-Nov-2024)
2/17 (11.76%)
$4.76 (27.61%)
878
Hold
$16
$-3.86 (-19.44%)
$15
1 months 11 days ago
(07-Nov-2024)
1/9 (11.11%)
$-1.9 (-10.61%)
11
Buy
$37
4 months 6 days ago
(12-Aug-2024)
22/26 (84.62%)
$16.35 (79.18%)
55
What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PCRX (Pacira Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?
Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?
Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?